TAICHUNG, TAIWAN (November 08, 2013) --Bio-medical Carbon Technology (BCT), a leading global wound dressing developer and manufacturer, announced the sponsorship to the International Wound Conference 2013, held in Kula Lumpur, Malaysia on October 18-20, 2013. As being one of the major conferences of wound care societies, each year, the conference attracts many wound care professionals to share their state-of-art experiences, techniques and researches. BCT, which develops and manufactures advanced wound dressings and brings a team of hard-working scientists and professionals together to provide better, safer and effective wound care products, was proudly to sponsor the conference. BCT has cooperated with physicians and doctors on many clinical researches. This year, BCT presented three clinical cases that were treated by KoCarbonAg, the flagship product which contains antimicrobial silver agent, or KoCarbon, a novel Activated Carbon medical product, and were fully healed and recovered.
Introduction of Clinical Cases Presented at International Wound Conference 2013
A 78-year-old female has hypertensive cardiovascular disease and disabled mobility, and had 2 chronic leg ulcers on both of her feet. The wound presented signs of infection, including purulent exudate, erythema, pain, and edema. Silver sulfadiazine and VAC (vacuum assisted closure) were combined to treat the deteriorated wound for one week, and systematic antibiotics were taken simultaneously to control infections. However, the result was not satisfied, and then debridement was reapplied on the infected area to remove slough tissue and covered with BCT Antimicrobial Dressing, KoCarbonAg®. The average dressing change was every 2 days and no other medication was taken during the period of treatment. After 20 days, wound infections were well managed and granulation tissue was appeared at the center of wounded area and the periphery of wound was restored with newly formed skin.
The patient had level 4 bed ulcer and no signs of infection. Doctor decided to stimulate the growth of granulation tissue to fill the wound cavity for the first priority and then perform the skin flap reconstruction to close the wound. So, according to the successful case of using KoCarbon® described above, the dressing was used to apply on the wound sites. After several weeks, the wound cavity was filled by newly grown granulation tissue and healed followed by the skin flap reconstruction.
Chronic venous insufficiency is impaired venous return, sometimes causing lower extremity discomfort, edema, and skin changes. Patients with this symptom always develop chronic ulcers that occur spontaneously or after affected skin are scratched or injured. This type of wound or ulcer tends to be shallow and moist, and may be malodorous (especially when poorly cared for) or painful. They do not penetrate into very deep. In contrast, ulcers due to peripheral arterial disease eventually expose tendons or bone. In this case, a patient with chronic venous insufficiency and an ulcer on the right opisthenar. The wound had not improved or showed any sign of healing for two years and the tissues in center of the wound has necrosis. We used KoCarbon® which can emit FIR that can increase the blood flow around the wound bed and to see if this dressing could bring out functions to improve the wound healing as developer described. The rate of dressing change was twice a day.
During the process of wound care described above, we found that the wound started growing granulation tissues and parts of the wound margin showed signs of re-epithelization. In addition, the red-ish or purple-ish colors around the wound bed had gradually faded which suggested the microcirculation had been improved by FIR emitted from KoCarbon®. One of the treatments for ulcers caused by venous insufficiency is increasing the blood flow so that will benefit the wound healing. Although we could not completely heal the wound in a short time of this case, color changes and the signs of growing granulation tissue gradually gave us a suggestion that the condition of the wound had been improved.
About Hsin-Chung Tsai, M.D.
Dr. Tsai is Head of Division of Plastic Surgery, Department of Surgery, Taichung Hospital, Ministry of Health and Welfare, Taiwan. He had previously served as an attending physician of plastic surgery in Taipei Veterans General Hospital and Taichung Veterans General Hospital.
About Tzong-Shiun Li, M.D., Ph.D.
Dr. Lee is Chairman of Plastic Surgery, Tainan Municipal An-Nan Hospital-China Medical University, Taiwan. He had previously served as an attending physician of Plastic and Reconstructive Surgery, Department of Surgery, E-Da Hospital.
About Bio-medical Carbon Technology
Bio-medical Carbon Technology, BCT, develops and manufactures ionic silver coated activated carbon fiber wound care dressings. Its products with proven effectiveness backed by the laboratory tests and clinical trials can treat a broad range of wound types, both acute and chronic wounds. It is proven that its products provide an easy, gentle, faster wound healing. BCT operates worldwide and is supported by its professionals and ongoing development and research. For more information, please visit www.bm-carbon.com